MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
  • Gait Activation Improves Hypomimia in Parkinson’s Disease

    S. Ismailova, S. Prokopenko, A. Khomchenkova (Krasnoyarsk, Russian Federation)

  • Gait Kinematics as Biomarkers of Preclinical Parkinson’s Disease: A Systematic Review of Sensor-Based Studies

    K. Makhoul, N. Elayan, K. Fisher, R. Ramdhani (New York, USA)

  • Gait parameters, Imaging features, and CSF tap test in idiopathic Normal Pressure Hydrocephalus (iNPH) Is composite testing the way to go

    A. Elavarasi, S. Poudel, A. Fasano, D. Dash, A. Wagle Shukla, A. Garg, A. Upadhyay, N. Wig, R. Rajan, A. Das, M. Tripathi, P. Chandra, A. Suri (New Delhi, India)

  • Gauging The Applicability Of The Global Assessment Scale for Wilson’s Disease in Brazil

    A. Oliveira Santos, I. Cerqueira, M. da Silva, B. Smith, L. Fonseca Matta, L. Silveira-Moriyama (Campinas, SP, Brazil)

  • GBA1 deficiency promotes tau and TDP-43 co-pathology

    A. Park, L. Lee, M. Kim, M. Callier, E. Chiu, C. Latimer, M. Davis (Seattle, USA)

  • GBA1 L444P mutation increases susceptibility to neuroinflammation and promotes pro-inflammatory immune responses

    R. Wang, D. Cossu, Y. Tomizawa, T. Hatano, N. Hattori (Bunkyo, Japan)

  • Gelsolin and Secretogranin-3 induce Parkinsonian features in rodent models.

    R. Raghu, S. Choudhury, P. Alladi (Bengaluru, India)

  • Gender Differences in Cervical Dystonia Patients

    L. Shperling, O. Druzhinina, D. Novotniy, L. Shchepankevich, N. Zhukova (Novosibirsk, Russian Federation)

  • Genetic analysis of Mongolian patients with Parkinson’s Disease

    B. Tserensodnom, KH. Tulgaa (Ulaanbaatar, Mongolia)

  • Genetic analysis of the SLC38A6 gene in Chinese patients with essential tremor

    HW. Wu, N. Jin, XS. Zheng, XH. Chen, WX. Bi, SY. Xie, ZD. Cen, DH. Yang, W. Luo (Lishui, China)

  • Genetic analysis of the X chromosome and Parkinson’s disease

    N. Kuznetsov, M. Makarious, K. Levine, D. Vitale, C. Blauwendraat, A. Singleton, H. Leonard (Washington, USA)

  • Genetic Architecture of Essential Tremor: Clinical Misdiagnosis and Structural Variant Contributions to Neurobiological Pathways

    X. Zheng, N. Jin, H. Wang, Z. Cen, W. Luo (Hangzhou, China)

  • Genetic Architecture Of Intracranial Brain Calcification: A Systematic Review

    S. Bandrivska, M. Bandrivskyi, T. Slobodin, H. Houlden, F. Magrinelli (London, United Kingdom)

  • Genetic determinants of cognitive performance in Parkinson’s disease: impact of distal regulatory variation at the SNCA locus in the gp2 cohort

    D. Náfate Wences, A. Cervantes Arriaga, M. Rodríguez Violante, MT. Periñán Tocino, GP2. Genetics Program (Mexico City, Mexico)

  • Genetic Disorders Presenting With Tremor at Onset: MDSGene systematic literature review

    V. Alakbarzade, E. Valente, F. Morgante (Carshalton, United Kingdom)

  • Genetic Landscape of Hereditary Ataxia in a Highly Consanguineous Population: A Nationwide Multicenter Study

    F. Alqahtani, H. Alqahtani, A. Binbakheet, Z. Alqahtani, A. Sayed, A. Alsayegh, O. Alghamdi, A. Alqahtani, T. Almejaish, A. Almatrafi, A. Alhashim, A. Alotaibi, A. Kentab, R. Alshawaf, M. Abukhalid, A. Aldokheel, S. Alshimemeri, S. Alqahtani, N. Kaya, M. Rifai (Riyadh, Saudi Arabia)

  • Genetic Modifiers of Age at Onset for Parkinson’s Disease in European Populations

    H. Leonard, L. Lange, M. Makarious, A. Singleton, C. Blauwendraat (Wasington, USA)

  • Genetic modifiers of the clinical phenotype in Spinocerebellar Ataxia type 2. 25 years of candidate genes studies and the forthcoming GWAS era

    L. Almaguer-Mederos (London, United Kingdom)

  • Genetic Predictors in Dystonia: A Phenotypic Analysis.

    N. Gowda, N. Kamble, V. Holla, R. Yadav, P. Pal (Bengaluru, India)

  • Genetic Rare Variation in Early-Onset Neurodegenerative Movement Disorders: A Clinicopathologic Study.

    T. Du Toit, L. Wu, O. Serrano, N. Kuznetsov, S. Love, A. King, F. Roncaroli, L. Parkkinen, C. Morris, C. Smith, G. Serrano, T. Beach, S. Gentleman, T. Warner, Z. Jaunmuktane, J. Carr, R. Real, H. Morris (London, United Kingdom)

  • Genetic risk factors reduce the risk of diabetes mellitus in Parkinsons disease

    EK. Tan, S. Chan, B. Tan, L. Tan, C. Chan (Singapore, Singapore)

  • Genetic spectrum of spinocerebellar ataxia type 27b (atx-fgf14-gaa): a single-center study

    A. Protsenko, N. Abramycheva, E. Nuzhnyi, S. Klyushnikov, S. Illarioshkin (Moscow, Russian Federation)

  • Genetic Variation in KCNJ6 Gene Increases Risk of Impulse Disorders in Parkinson’s Disease: A Two-Cohort Study

    S. García-Díaz, J. Martín-Rodríguez, L. Muñoz-Delgado, R. Díaz-Belloso, S. Jesús, MT. Periñán, M. Martín-Bórnez, AM. Castellano-Guerrero, E. Ojeda-Lepe, D. Macías-García, A. Adarmes-Gómez, D. Buiza-Rueda, M. Bonilla-Toribio, E. Iglesias-Camacho, M. San-Eufrasio, C. Pérez-Calvo, A. Luque-Ambrosiani, F. Carrillo-García, P. Gómez-Garre, P. Mir (Sevilla, Spain)

  • Genetically proven Juvenile-Onset Niemann–Pick Disease Type C Presenting with Dystonia- Ataxia syndrome.

    A. Ranjan, A. Kumar, A. -, N. Sinha, A. Kumar, P. Anand (Patna, India)

  • Genome-wide Discovery of GBA1 Modifiers in Parkinsons Disease Carriers across Populations from the Global Parkinsons Genetics Program

    M. Makarious, L. Lange, Z. Fang, A. Singleton, C. Blauwendraat, H. Leonard (Washington, USA)

  • Genome-wide Discovery of Genetic Modifiers of LRRK2 risk in Parkinson’s Disease Carriers across European Populations

    H. Leonard, L. Lange, M. Makarious, Z. Fang, C. Blauwendraat, A. Singleton (Wasington, USA)

  • Genomic analysis of an Argentinean PSP cohort

    N. Fonseca, I. Paez-Paz, G. Mizraji, L. Brolese, MJ. Angel, MC. Peralta, M. Mezmezian, G. Sevelver, O. Gershanik, T. Falzone, B. Couto, ME. Avale (Buenos Aires, Argentina)

  • Genomic Insights into Parkinson’s Disease: LARGE-PD and PD GENEration Collaboration in El Salvador

    S. Peña Martínez, T. Ascencio, R. de León, I. Mata (SS, El Salvador)

  • Genotype Matters: Vagus Nerve Atrophy in GBA-Associated Parkinson’s Disease

    J. Di Giovanni, D. Genovese, G. Granata, G. Di Lazzaro, F. Tomasello, A. Cimmino, M. Patera, A. de Biase, M. Petracca, C. Piano, F. Bove, A. Bentivoglio, P. Calabresi (Rome, Italy)

  • Genotype-Phenotype Correlations in KCNMA1 Channelopathy: A Comparative Analysis of Gain-of-Function and Loss-of-Function Variants in a Korean Cohort and Literature Review

    JM. Kim, S. Lee, SY. Kim, J. Moon, JH. Chae (Seoul, Republic of Korea)

  • Genotype-Specific Risk Factors for Falls in Spinocerebellar Ataxia: A Cross-Sectional Analysis of SCA1, SCA2, SCA3, and SCA6

    S. Kakde, Y. Lin, S. Kuo (New York, USA)

  • Global and Turkish Comorbidity Profiles in Parkinson’s Disease: The ANPAR Cohort and a Systematic Review

    T. Abali, I. Koker, Z. özdamar, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)

  • Global Functional Trajectory and Predictors of Improvement in Idiopathic Normal Pressure Hydrocephalus Following Shunt Surgery

    C. Wisherop, H. Shaqra, F. Price, C. Andy, A. Ricaurte-Fajardo, A. Yoo, D. Victor, M. Salgado, R. Richardson, D. Ugo-Omenukwa, J. Ivanidze, G. Chiang, A. Nordvig, M. Lin, S. Blum, M. Hamed (New York, USA)

  • Global Momentum in Parkinson’s Disease Therapeutics: Ten-Year Trends in Mechanisms, Modalities, and Clinical Endpoints

    L. Gutiu, A. Fuller, A. Todorova (Durham, USA)

  • Global Parkinson´s Symptoms Index Correlates with Changes in Quality of Life and Autonomy for Activities of Daily Living

    D. Santos García, B. Solano, E. Cubo, S. Escalante, L. Vela, M. Seijo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, B. Pascual Sedano, I. Pareés Moreno, I. Gastón, M. Menéndez González, M. Kurtis, C. Ordás, C. Valero, J. Ruíz Martínez, R. Alonso Redondo, SG. Coppadis (A Coruña, Spain)

  • Global Performance Patterns in the MDS-UPDRS Motor Certification Program: A five-year Analysis

    C. Falup-Pecurariu, C. Akbostanci, E. Bayram, I. Estrada-Bellmann, J. Ma, T. Mestre, I. Murasan, O. Ojo, P. Pal, M. Qamar, F. Rodriguez-Porcel, A. Sanchez Ferro (Brasov, Romania)

  • Global Roles of Nurses and Advanced Practice Providers in Parkinson’s Disease Care: Findings from an International Workforce Survey

    K. Papesh, C. Goas, N. Bryden, B. Aparente, F. Chmell, J. Miravite, A. Roszmann, L. Wei, J. Nguyen, E. Zinn, C. Kyinn, D. Tsui, ML. Greschner, S. Gould (Henderson, USA)

  • Global Trends in Parkinson’s Disease Research: A Bibliometric Snapshot (2021–2024)

    R. Mansour, F. Namnom, A. Ali, I. Hanafi (Latakia, Syrian Arab Republic)

  • Globus Pallidus Internus Deep Brain Stimulation for Dystonia in COX20-Related Mitochondrial Complex IV Deficiency (MC4DN11): First Reported Case

    R. Toklu çetinkaya, N. Durmaz çelik, S. özkan (eskişehir, Turkey)

  • GLP-1 Receptor Agonists in Movement Disorders: From Parkinson’s Disease to the Broader Spectrum — Mechanisms, Evidence, and Future Directions

    A. Dahshan (Cairo, Egypt)

  • GLP1R Expression and Parkinson’s Disease and Related Disorders in GLP-1RA–Treated Type 2 Diabetes

    KA. Woo, Y. Jang, P. Park, HJ. Kim (Seoul, Republic of Korea)

  • Glymphatic dysfunction in patients with Parkinson’s disease is associated with regional amygdala and putamen degeneration

    C. Garcia-Vicente, J. Pardo, C. Martín-Barceló, I. Roura, C. Falcon, R. Sala-Llonch, A. Campabadal, C. Uribe, N. Bargalló, O. Brengaret, C. Brenlla, C. Painous, A. Cámara, M. Buongiorno, M. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

  • Grey Matter Volume and White Matter Microstructural Alterations in PRKN-PD

    HT. Wang, F. Xie, B. Wang, W. Luo (Hangzhou, China)

  • Grip strength and hand distress in de novo Parkinson´s disease: support for early rehabilitation

    A. Szymanska, E. Franzén, L. Dahlin, S. Grigoriou, B. Lindholm (Malmö, Sweden)

  • GSTM1 and GSTT1 null genotypes as candidate modifiers of clinical severity and genomic instability in Cuban patients with Spinocerebellar Ataxia type 2

    D. Cuello-Almarales, R. Aguilera-Rodríguez, D. Almaguer-Gotay, L. Osorio-González, L. Almaguer-Mederos (Holguin, Cuba)

  • Gut Barrier Failure In Parkinson Disease: Reduced Colonic Resilience In Moderate Disease And Spontaneous Pan-Intestinal Leak In Severe Disease

    M. Abdel-Mohsen, M. Shaikh, L. Zhang, P. Engen, C. Neumann, M. Villanueva, D. Sanchez-Bass, L. Dibenedetto, S. Luo, B. Killinger, C. Soto, S. Green, L. Lagorio, R. Voigt, A. Sharma, C. Goetz, A. Keshavarzian (Chicago, USA)

  • Gut Microbiome Metagenomics in Parkinson’s Disease Stratified by the Asian-Prevalent LRRK2 Variants p.G2385R and p.R1628P

    TS. Toh, JW. Hor, CH. Lin, J. Tee, Z. Pan, AK. Ng, V. Balakrishnan, AN. Khairul Anuar, LC. Lit, CW. Chong, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)

Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley